neurobopharma.com (NRBO) - Uzoq muddatli majburiyatlarning kapitalga nisbati
NeuroBo Pharmaceuticals (NRBO) aksiyalari narxidagi bozor tebranishlari 0.01 miqdoridagi uzoq muddatli qarzning kapitalga nisbati dinamikasini aks ettiradi. Biznes nevrologik va metabolik patologiyalar uchun dori vositalarini ishlab chiqishga tayanadi, bunda patentlar daromadning barqaror oqimini kafolatlaydi. NeuroBo Pharmaceuticals ilmiy markazlar bilan hamkorlikda semizlik va jigar kasalliklarini davolash terapiyalarini ishlab chiqmoqda. Investorlarning yuqori ishonchi va Koreya holding kompaniyasining qo'llab-quvvatlashi uning istiqbolli ishlab chiquvchi sifatidagi maqomini tasdiqlaydi.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261031&filename=GURU_Markets_-_NRBO_-_NeuroBo-Pharmaceuticals_-_Long-Term-Debt-to-Equity-Ratio "NRBO - NeuroBo Pharmaceuticals, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 07.12.2024 oraligʻida | 👁️GURU.Markets👁️")
NeuroBo Pharmaceuticals kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati NeuroBo Pharmaceuticals|NRBO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi neurobopharma.com|NRBO - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar NeuroBo Pharmaceuticals, Inc.|NRBO - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari NeuroBo Pharmaceuticals|Oraliq qoplash koeffitsiyenti neurobopharma.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:NRBO (NeuroBo Pharmaceuticals Inc)
Barqaror portfelni shakllantirish uchun men kompaniyaning o'z majburiyatlarini defolt xavfisiz bajarish qobiliyatini baholayman. Ushbu ko'rsatkich muddati bir yildan ortiq bo'lgan kreditlar hajmini umumiy kapital bilan solishtiradi. NeuroBo Pharmaceuticals uchun ushbu balans o'sib borayotgan nevrologik dori vositalari segmentidagi qimmat ishlab chiqishlar moliyalashtirilayotganda hal qiluvchi ahamiyatga ega. Uzoq muddatli leveraj ko'rsatkichini tahlil qilish orqali investor biznesning qarzga bog'liqlik darajasini aniqlaydi. Ushbu egri chiziq dinamikasi kapital tuzilmasining fundamental mustahkamligini tasdiqlaydi.
Raqobatdosh kompaniyalar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi HRMY (harmonybiosciences.com)|Uzoq muddatli qarzning kapitalga nisbati BHVN|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Trevi Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Praxis Corp PRAX|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CBLL (ceribell.com)|Prothena Corp (PRTA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alector (ALEC)|ANNX (Annexon Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati OMER|Uzoq muddatli qarzning o'z kapitaliga nisbati Neurogene Inc. (NGNE)|ACIU - Uzoq muddatli majburiyatlarning kapitalga nisbati|Voyager Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti NMRA|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati TVGN|ACOG: Uzoq muddatli qarzning kapitalga nisbati|cogrx.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Cassava Sciences Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|COYA (coyatherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Vistagen VTGN|OVID - Uzoq muddatli qarzning o'z kapitaliga nisbati|Acumen Pharmaceuticals, Inc. - Uzoq muddatli qarzning kapitalga nisbati|CRVO - Uzoq muddatli qarzning kapitalga nisbati|ATHE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Clene|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati jupiterneurosciences.com JUNS|Uzoq muddatli qarzning o'z kapitaliga nisbati RLMD (Relmada Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Annovis Bio Inc (ANVS)|Grace Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati AIFF (Firefly Neuro)|ANEW Medical, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati NeuroSense Therapeutics NRSN|RVPH: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati MetaVia|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Helius Medical Technologies Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio, Inc. (PASG)|Uzoq muddatli qarzning o'z kapitaliga nisbati NEUP (bionomics.com.au)|Uzoq muddatli qarzning o'z kapitaliga nisbati Minerva Neurosciences, Inc. NERV|Uzoq muddatli qarzdorlikning kapitalga nisbati Athira Pharma Inc (ATHA)|ADXN - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALZN (Alzamend Neuro, Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|cyclerion.com (CYCN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Protagenic Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|KTTA (Pasithea Therapeutics Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CRGT|Uzoq muddatli qarzning o'z kapitaliga nisbati Avenue Therapeutics, Inc (ATXI)|BCLI - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cara Therapeutics, Inc. CARA|CHRO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Eliem - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Intra-Cellular Therapies|LBPH (Longboard Pharma) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Marinus Pharma (MRNS) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NKGen Biotech, Inc.|SAGE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|TRVN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|WENA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati